Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Effective Immediately, Solvay Licenses MediTECH® to Supply Zeniva® PEEK Shapes

MediTECH®, a registered trademark of the Mitsubishi Chemical Advanced Materials group, announces a new licensing agreement with Solvay to fulfill customer orders for extruded stock shapes made with Solvay's Zeniva® PEEK. The agreement, which names MediTECH® as Solvay's licensee for the global fulfillment of Zeniva® PEEK extruded shapes, will take effect immediately. The new licensing agreement expands MediTECH's existing role in the longstanding partnership between the two companies, with the goal of bringing additional value to the customer channel.


News provided by

Mitsubishi Chemical Advanced Materials

Oct 18, 2019, 05:00 ET

Share this article

Share toX

Share this article

Share toX

Zeniva® PEEK high-performance biocompatible polymer
Zeniva® PEEK high-performance biocompatible polymer

READING, Pa., Oct. 18, 2019 /PRNewswire-PRWeb/ -- Stock shapes produced from Zeniva® PEEK, high-performance biocompatible polymers, are used primarily for orthopedic, cardiac and neurological implantable devices . Performance benefits of Zeniva® PEEK shapes include biostability, high strength and stiffness, fatigue resistance and exceptional dimensional stability. These shapes are ideal for the close tolerance machining of finished components, and for prototypes used in injection molding applications. Additionally, Zeniva® PEEK stock shapes have numerous advantages over metals, such as a reduction in stress shielding, no heavy metal allergy or ion erosion, and radiolucent properties which allow x-ray and CT scanning procedures to occur without interference.

"We are very excited to further our implantable shapes strategy with the addition of Zeniva® PEEK, which complements our existing portfolio of UHMW implantable products. In conjunction with MediTECH'S unique "Near Net" manufacturing technology, we can provide customers with productivity improvements and a simplified supply chain" says Eric Tech, Global Market Manager for the Medical industry at Mitsubishi Chemical Advanced Materials. Matt Donahey, MediTECH'S® Global Director, states that "As a global leader whose manufacturing facilities are certified under ISO 13485, MediTECH® can also provide customers with deep expertise in regulatory, compliance, and supply chain management. For more than 30 years, Mitsubishi Chemical Advanced Materials' MediTECH® Division has supplied leading orthopedic implantable device manufacturers with premium implantable-grade UHMW-PE under the Chirulen® and Extrulen® brand names."

“This licensing agreement underscores our commitment to make it easier for customers to do business with Solvay and our partners,” said Jeff Hrivnak

Post this

Jeff Hrivnak, Global Business Manager for Healthcare at Solvay's Specialty Polymers global business unit adds, "This licensing agreement underscores our commitment to make it easier for customers to do business with Solvay and our partners. By reassigning fulfillment activities to MediTECH®, our customers will also benefit from their deep expertise in regulatory requirements, as well as polymer shape technologies."

Both companies- MediTECH® and Solvay- are excited to enter into this new agreement that stems from a long history and partnership. Mitsubishi Chemical Advanced Materials has manufactured Solvay's Zeniva® PEEK shapes since the material's inception 12 years ago. Zeniva® PEEK resin and stock shapes comply with ISO 13485 manufacturing standards and meet current Good Manufacturing Practices (GMP). Based on rigorous biocompatibility testing, these products demonstrate no evidence of cytotoxicity, sensitization, irritation, or acute systemic toxicity as defined by ISO 10993. These products can be sterilized using all conventional methods, including gamma radiation, ethylene oxide, and steam.

About Mitsubishi Chemical Advanced Materials

With more than 80 years of experience, 30 branch offices in 20 countries, and a team of technical service experts, engineers, and application development managers, Mitsubishi Chemical Advanced Materials** is the global leader for researching, developing, and manufacturing high-performance engineered polymer materials. Our products make the world a safer place by providing solutions across all industries- food processing and packaging, aerospace and defense, semiconductor, oil and gas, medical and life sciences, renewable energy, construction and heavy equipment, and electronics.

Registered trademarks of Mitsubishi Chemical Advanced Materials include: Acetron®, CleanStat®, Duratron®, Ertalyte®, Ertalene®, Ertalon®, Fluorosint®, Ketron®, Nylatron®, Proteus®, Sanalite®, Semitron®, Techtron®, and TIVAR®. Learn more at http://www.mcam.com and on LinkedIn at https://www.linkedin.com/company/mcamconnect/

**Mitsubishi Chemical Advanced Materials, formerly Quadrant EPP, was officially named on April 1st, 2019. The Quadrant Group was established in 2001 and acquired by Mitsubishi Chemical Corporation in 2013.

About MediTECH®

For more than 30 years, Mitsubishi Chemical Advanced Materials' MediTECH® Division has supplied leading orthopedic implant manufacturers with premium implantable grade UHMW-PE under the Chirulen® and Extrulen® brand names. Due to their superior physical and mechanical properties, cleanliness and consistency, Chirulen® and Extrulen® have become the materials of choice for helping restore a higher quality of life to millions of patients worldwide.

About Solvay

Solvay is an advanced materials and specialty chemicals company, committed to developing chemistry that addresses key societal challenges. Solvay innovates and partners with customers worldwide in many diverse end markets. Its products are used in planes, cars, batteries, smart and medical devices, as well as in mineral and oil and gas extraction, enhancing efficiency and sustainability. Its light weighting materials promote cleaner mobility, its formulations optimize the use of resources and its performance chemicals improve air and water quality. Solvay is headquartered in Brussels with around 24,500 employees in 61 countries. Net sales were €10.3 billion in 2018, with 90% from activities where Solvay ranks among the world's top 3 leaders, resulting in an EBITDA margin of 22%. Solvay SA (SOLB.BE) is listed on Euronext Brussels and Paris Bloomberg: SOLB.BB - Reuters: SOLB.BR), and in the United States its shares (SOLVY) are traded through a level-1 ADR program. Financial figures take into account the planned divestment of Polyamides.

Solvay Specialty Polymers manufactures over 1500 products across 35 brands of high-performance polymers – fluoropolymers, fluoroelastomers, fluorinated fluids, semi-aromatic polyamides, sulfone polymers, ultra-high performance aromatic polymers, and high barrier polymers – for use in Aerospace, Alternative Energy, Automotive, Healthcare, Membranes, Oil and Gas, Packaging, Plumbing, Semiconductors, Wire & Cable, and other industries. Learn more at http://www.solvayspecialtypolymers.com.

For additional questions and media inquiries, please contact Kathena Siegel at Mitsubishi Chemical Advanced Materials.

SOURCE Mitsubishi Chemical Advanced Materials

Related Links

http://www.mcam.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.